Brian Lee Baker, SVP of Finance and Administration at Turning Point Therapeutics, Inc. (TPTX), sold 31,751 shares at $122.44 ($3.9M) on 2021-01-07, disclosed to the SEC on 2021-01-08.
Open-market sale of $3.9M TPTX by SVP of Finance and Administration. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $120.16 | 900 | $108K | 2.8% |
| 2 | $121.57 | 5,200 | $632K | 16.3% |
| 3 | $122.44 | 21,825 | $2.7M | 68.8% |
| 4 | $122.65 | 2,800 | $343K | 8.8% |
| 5 | $123.02 | 513 | $63K | 1.6% |
| 6 | $123.02 | 513 |
| $63K |
| 1.6% |
| Total | $122.27 avg | 31,751 | $3.9M | 100% |
| Filing → |